Brutalna prawda o OTYŁOŚCI. To NIE insulinooporność! | prof. Leszek Czupryniak

Key wellness & health strategies discussed

• Reframe “insulin resistance”

  • Prof. Leszek Czupryniak argues insulin resistance is not a standalone disease, but a physiological response that often reflects excess body fat/obesity.
  • He emphasizes that focusing treatment on insulin numbers (rather than the underlying cause) can be misleading.

• Primary target: treat obesity (the “real disease”)

  • Core idea: excess weight is the main problem, and insulin-related changes are a consequence of how fat cells and tissues behave.
  • The “wellness plan” is centered on:
    • weight loss
    • diet changes
    • increased movement/activity

• Use exercise as a major insulin-sensitivity tool

  • Activity/exercise (including walking and general movement) improves glucose handling because muscles burn glucose more effectively.
  • Highlighted mechanism: with activity, muscles use glucose roughly ~10x more.

• Stress the importance of sustainable lifestyle change

  • He notes that short bursts (“one month” changes) usually fail long-term.
  • Effective change often requires structural changes (environment, routine, supports), not just motivation.

• When lifestyle alone is insufficient: consider obesity medications

  • He argues obesity is a serious chronic disease, and lifestyle alone may not work for significantly overweight people.
  • He promotes GLP-1 / GIP-based anti-obesity drugs to help people eat less and move more.

• Medication + dietitian support (especially with GLP-1 type therapy)

  • He recommends working with an experienced dietitian, particularly during GLP-1 treatment.
  • Key point: as intake drops, food quality/adequacy matters—including preserving strength and muscle.
  • A clinic dietitian and their patient education resources (book) were mentioned.

• Don’t rely on confusing or potentially unhelpful testing

  • He criticizes an “insulin-focused” approach, especially:
    • Oral glucose tolerance testing when interpretation encourages fear about insulin levels.
  • He suggests HbA1c can be a more practical marker for glucose balance for many people (with caveats).

• Mental health link: weight struggles are bidirectional with depression/anxiety

  • The discussion includes how:
    • depression/anxiety can increase risk of weight gain (e.g., “depressive eating” and reduced activity)
    • long-term obesity and stigma can worsen mood and mental health
  • Obesity treatment is framed as affecting self-esteem, energy, and quality of life—not only lab values.

• Psychological/productivity-adjacent takeaway (from an earlier promo)

  • The promo criticizes “strong resolution → reality clash → back to square one.”
  • Suggested strategy:
    • follow a personalized plan, not generic willpower-based dieting
    • use app-based support and dietitian chat for adherence

---

Self-care / lifestyle tactics explicitly mentioned

Nutrition

• Reduce calorie intake (framed as obesity treatment)
• Decrease snacking between meals (especially emphasized with GLP-1-related mechanisms)
• Prioritize food quality once portions shrink (with dietitian guidance)

Movement

• Increase daily activity (walking, cycling, swimming, running—general “being active”)
• Avoid purely sedentary behavior after meals (resting after eating may increase the likelihood of glucose being stored as fat, per the subtitles)

Behavior change

• Create structural, long-term changes to routine/environment (not just temporary discipline)

Medical self-advocacy

• Ask doctors what decision they would make based on insulin levels
• Request clarity on whether the core issue is obesity/diabetes risk versus “insulin resistance” as a disease

---

Presenters / sources mentioned

• Prof. Leszek Czupryniak

  • Internal medicine & diabetology; Head of Diabetology and Internal Medicine Clinic, Medical University of Warsaw

• Psychologist Dawid Straszak

  • Mentioned in the intro/promo for the “charismatic podcast”

• Respo Center

  • Mentioned as a wellness/diet program partner in the subtitles’ advertisement

• Maja Sosnowska

  • Dietitian; co-author mentioned for a book on obesity “miracle injections”

• Professor David Matthews (credited with the HOMA/Homo index concept mentioned)

• Marek Ruchała

  • Endocrinologist; co-author mentioned for an article: “Insulin Resistance as a Pseudo-Disease”

• UKPDS / United Kingdom Prospective Diabetes Study (1998)

  • Cited regarding insulin safety in type 2 diabetes

• ICD

  • International Classification of Diseases; referenced regarding whether insulin resistance is or isn’t coded as a disease